Engineered organoid platforms for drug delivery evaluation.
Advanced biomaterials and drug delivery systems (DDSs) require human-relevant models that can capture tissue heterogeneity, physiological barriers, and patient-specific therapeutic responses. Conventional two-dimensional cultures and animal models often fail to reproduce these features, contributing to discrepancies be...